SAM
BNTX icon

SEB Asset Management’s BioNTech BNTX Stock Holding History

SEB Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8M Buy
245,068
+44,960
+22% +$4.23M 0.09% 204
2026
Q1 		$17.8M Buy
+200,108
New +$20.6M 0.08% 217

Other funds holding BNTX

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

SEB Asset Management's BNTX Position: Q2 2026 in Review

SEB Asset Management increased its BioNTech (BNTX) stake by 22% in Q2 2026, buying an estimated $4.23M and bringing the position to 245,068 shares worth $22.8M. The position accounts for 0.09% of the portfolio, ranked #204.

SEB Asset Management first reported a position in BNTX in Q1 2026 and has held it in 2 quarters since. 263 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • SEB Asset Management held 245,068 shares of BioNTech worth $22.8M as of Q2 2026.
  • SEB Asset Management bought 44,960 BioNTech shares in Q2 2026, an estimated $4.23M.
  • BioNTech made up 0.09% of SEB Asset Management's portfolio in Q2 2026, its #204 holding.
  • SEB Asset Management first reported a position in BioNTech in Q1 2026 and has held it in 2 quarters since.
  • 263 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.